Product Information
VALSARTAN 160 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1123 per EA under NDC 59746036290. Its NADAC has been published 561 times since Mar 11, 2015.
FDA first approved this application on Jan 5, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
160 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746036290
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203536FDA Approved
1/5/2015
TE Code
AB
On Market Since
1/5/2015
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 160 MG TABLET has been published 561 times since Mar 11, 2015, and over the history we have for it it has declined 96.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1123 per EA |
|---|---|
| All-time high | $3.3182 (Mar 11, 2015) |
| All-time low | $0.0929 (Jan 17, 2018) |
| 52-week high | $0.1410 |
| 52-week low | $0.1123 |
| Median price | $0.2336 |
| Average price | $0.2526 |
| Largest weekly change | +116.9% (Oct 17, 2018) |
| Weeks tracked | 561 |
| Tracking since | Mar 11, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALSARTAN 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 160 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1123 per EA (NDC 59746036290), effective Aug 19, 2026.
How has the price of VALSARTAN 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 160 MG TABLET has declined 96.6%. It has been tracked across 561 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for VALSARTAN 160 MG TABLET?
Since Mar 11, 2015, the NADAC for VALSARTAN 160 MG TABLET has ranged from a low of $0.0929 (Jan 17, 2018) to a high of $3.3182 (Mar 11, 2015), with a median of $0.2336 per EA.
Are there cheaper alternatives to VALSARTAN 160 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN 160 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN 160 MG TABLET?
VALSARTAN 160 MG TABLET (NDC 59746036290) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.